Oncolytics Biotech Inc
(MENAFN- Baystreet) 12:07 PM EST - Oncolytics Biotech Inc: Announced translational data in heavily pretreated relapsed/refractory multiple myeloma patients, which will be presented at the 68th American Society of Hematology Annual Meeting and Exposition. Oncolytics Biotech Inc
shares N are trading unchanged at $0.43.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment